Blog

Sara Elena Rebuzzi: Study protocol of the ongoing study on the first-line therapy in mRCC patients

Photo taken from Sara Elena Rebuzzi/LinkedIn

Jul 1, 2024, 17:38

Sara Elena Rebuzzi: Study protocol of the ongoing study on the first-line therapy in mRCC patients

Sara Elena Rebuzzi, Medical Oncologis at The Hospital of San Paolo, made the following post on LinkedIn:

“Finally published the study protocol of the ongoing prospective/retrospective study on the first-line therapy in mRCC patients!! 520 patients enrolled, but the number is progressively increasing!!

DOI: 10.1186/s12885-024-12319-1.”

Source: Sara Elena Rebuzzi/LinkedIn
.

cancer cancer treatment clinical study first-line therapy Hospital of San Paolo medical oncologist metastatic renal cell carcinoma mRCC OncoDaily Oncology oncology research prospective study Research retrospective study Sara Elena Rebuzzi study protocol

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage